Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-02-22 @ 4:14 PM
Study NCT ID:
NCT02126358
Status:
COMPLETED
Last Update Posted:
2016-10-18
First Post:
2014-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)
Sponsor:
LG Life Sciences
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LG-GSCL002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None